Page 99 - GALENIKA MEDICAL JOURNAL

20. Bhandari S, Mehta S, Khwaja A, Cleland JGF, Ives N, Brettell E, et al; 25. Holtkamp FA, de Zeeuw D, Thomas MC, Cooper ME, de Graeff PA,
STOP ACEi Trial Investigators. Renin-Angiotensin System Inhibition Hillege HJ, et al. An acute fall in estimated glomerular filtration rate
in Advanced Chronic Kidney Disease. N Engl J Med. 2022 Dec during treatment with losartan predicts a slower decrease in long-term
1;387(22):2021-32. renal function. Kidney Int. 2011 Aug;80(3):282-7.
21. Fu EL, Evans M, Clase CM, Tomlinson LA, van Diepen M, Dekker FW, 26. Sinha AD, Agarwal R. Clinical Pharmacology of Antihypertensive
et al. Stopping Renin-Angiotensin System Inhibitors in Patients with Therapy for the Treatment of Hypertension in CKD. Clin J Am Soc
Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study. J Nephrol. 2019 May 7;14(5):757-64.
Am Soc Nephrol. 2021 Feb;32(2):424-35.
27. Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al;
22. Ruggenenti P, Perna A, Remuzzi G. ACE inhibitors to prevent end-stage FIDELIO-DKD Investigators. Effect of Finerenone on Chronic Kidney
renal disease: when to start and why possibly never to stop: a post hoc Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020 Dec
analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am 3;383(23):2219-29.
Soc Nephrol. 2001 Dec;12(12):2832-7.
23. Remuzzi G, Ruggenenti P, Perna A, Dimitrov BD, de Zeeuw D, Hille DA,
et al; RENAAL Study Group. Continuum of renoprotection with losartan Konflikt interesa: Nema
at all stages of type 2 diabetic nephropathy: a post hoc analysis of the
RENAAL trial results. J Am Soc Nephrol. 2004 Dec;15(12):3117-25. Primljeno: 07. 02. 2023.
24. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, et al. Efficacy Prihvaćeno: 22. 03. 2023.
and safety of benazepril for advanced chronic renal insufficiency. N Onlajn: 01. 06. 2023.
Engl J Med. 2006 Jan 12;354(2):131-40.

SMJERNICE I PREPORUKE Galenika Medical Journal, 2023; 2(6):91-97. 97